ֱ's highly accurate trace gas analyzers can continuously monitor N compounds (NOx, NO2, NO) to help clarify the cause of nitrosamine formation during the process of API* and formulation of pharmaceutical manufacturing.
Recently, nitrosamines, which are likely carcinogenic to humans, have been detected globally in the pharmaceuticals such as Sartan class of drugs. The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) recommend efforts to prevent the formulation of nitrosamines. Additionally, Japanese Ministry of Health, Labour and Welfare (MHLW) has notified pharmaceutical manufacturers and distributors to conduct self-inspections to assess the risk of nitrosamine contamination. The mechanism of nitrosamine formation is still under research, but one hypothesis suggests atmospheric N compounds could cause nitrosamine formation when ambient air is heated and used for drying formulation during the granulation process.
*API: Active Pharmaceutical Ingredient
Ventajas del APNA-380
Monitor de óxidos de nitrógeno APNA-380
Analizador de óxidos de nitrógeno
Analizador de amoniaco ambiental
Analizador de distribución de tamaño de partículas por dispersión láser
Tiene alguna pregunta o solicitud? Utilice este formulario para ponerse en contacto con nuestros especialistas.